Insider Transactions in Q1 2023 at Oncternal Therapeutics, Inc. (ONCT)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 03
2023
|
Richard G Vincent Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,428
-3.37%
|
$4,428
$1.02 P/Share
|
|
Jan 03
2023
|
Salim Yazji Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,961
-6.66%
|
$9,961
$1.02 P/Share
|
|
Jan 03
2023
|
Gunnar F. Kaufmann Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,266
-8.58%
|
$6,266
$1.02 P/Share
|
|
Jan 03
2023
|
Chase C. Leavitt General Counsel/Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
6,091
-6.92%
|
$6,091
$1.02 P/Share
|
|
Jan 03
2023
|
James B Breitmeyer Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Indirect |
1,325
-5.25%
|
$1,325
$1.02 P/Share
|
|
Jan 03
2023
|
James B Breitmeyer Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
27,793
-4.88%
|
$27,793
$1.02 P/Share
|
|
Jan 03
2023
|
Rajesh Krishnan CTO/CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,238
-8.55%
|
$6,238
$1.02 P/Share
|